A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01)
Patent
CA 2103805
The use of (E)-4-[2-[3-(1,1-dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4- dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester (lacidipine) for the treatment and/or prevention of arteriosclerosis.
Glaxo S.p.a.
Riches Mckenzie & Herbert Llp
LandOfFree
Use of lacidipine for the treatment of arteriosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of lacidipine for the treatment of arteriosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lacidipine for the treatment of arteriosclerosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2063538